Intercept to Announce First Quarter 2021 Financial Results on May 6, 2021

Rhea-AI Summary

Intercept Pharmaceuticals (Nasdaq:ICPT) will announce its Q1 2021 financial results on May 6, 2021, before the market opens. A conference call is scheduled for 8:30 a.m. ET on the same day to discuss the results. The call will be accessible via the company's investor page and through international dialing options. Intercept focuses on novel therapeutics for progressive non-viral liver diseases such as primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH), with operations in the U.S., Europe, and Canada.

NEW YORK, April 26, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, will announce its first quarter 2021 financial results prior to market open on Thursday, May 6, 2021. The announcement will be followed by a conference call and audio webcast hosted by Intercept management at 8:30 a.m. ET to discuss the results.

The conference call will be available on the investor page of our website at http://ir.interceptpharma.com or by calling (888) 517-2458 (toll-free domestic) or (847) 413-3538 (international) passcode 9873 994. Archived webcasts will be available on Intercept’s website for approximately two weeks.

About Intercept

Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada. For more information, please visit www.interceptpharma.com or connect with the company on Twitter and LinkedIn.

CONTACT

For more information about Intercept, please contact:

Investor inquiries: 
investors@interceptpharma.com

Media inquiries:
media@interceptpharma.com

Source: Intercept Pharmaceuticals, Inc.

FAQ

When will Intercept Pharmaceuticals announce its Q1 2021 financial results?

Intercept Pharmaceuticals will announce its Q1 2021 financial results on May 6, 2021.

What time is the Intercept Pharmaceuticals Q1 2021 conference call?

The conference call will take place at 8:30 a.m. ET on May 6, 2021.

How can I listen to the Intercept Pharmaceuticals conference call?

The conference call can be accessed via the investor page on Intercept's website or by calling designated numbers provided in their announcement.

What is the focus of Intercept Pharmaceuticals?

Intercept Pharmaceuticals focuses on the development of therapeutics for progressive non-viral liver diseases, including PBC and NASH.